The peptide synthesis market is expanding rapidly, driven by the rising incidence of chronic diseases like cancer, diabetes, and cardiovascular conditions. This surge in demand is fueled by the ...

Granules India has acquired Swiss CDMO company Senn Chemicals AG for Rs 192 crore, expanding its peptide therapeutics market ...

Generic drugmaker Granules India is foraying into the peptide segment and contract development and manufacturing organisation ...

In a bid to break into the CDMO business at one of its most lucrative angles, India's Granules is snapping up Swiss contract ...

With this acquisition, Granules gains capabilities in high-growth peptide-based therapeutics. It also aims to enter the ...

Hyderabad: Granules India Limited has announced the signing of the acquisition agreement regarding Senn Chemicals AG, a Swiss ...

Granules India advanced 1.95% to Rs 519 after the company said that its board has approved to acquire 100% stake in Senn Chemicals AG, a Switzerland based company, for a total consideration of Rs 192.

GLP-1 receptor agonists are transforming obesity treatment, but manufacturing challenges must be addressed to meet rising ...

For its entry into fast growing peptide segment and strengthen its CDMO biz ...